Structural insights into the tumor-promoting function of the MTDH-SND1 complex

Cell Reports

Volumn 8, Issue 6, 2014, Pages 1704-1713

  Guo, Feng ^a,c   Wan, Liling ^b   Zheng, Aiping ^a   Stanevich, Vitali ^a   Wei, Yong ^b   Satyshur, Kenneth A ^a   Shen, Minhong ^b   Lee, Woojong ^a   Kang, Yibin ^b   Xing, Yongna ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; METADHERIN; STAPHYLOCOCCAL NUCLEASE DOMAIN CONTAINING 1 PROTEIN; TRYPTOPHAN; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; HYBRID PROTEIN; MTDH PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN BINDING; SND1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BREAST CANCER; BREAST CARCINOGENESIS; CELL STRESS; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG TARGETING; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TUMOR PROMOTION; ANIMAL; BIOSYNTHESIS; CHEMISTRY; GENETICS; HUMAN; HYDROGEN BOND; METABOLISM; MOLECULAR DYNAMICS; PROTEIN TERTIARY STRUCTURE; SITE DIRECTED MUTAGENESIS; STATIC ELECTRICITY; TUMOR CELL LINE; X RAY CRYSTALLOGRAPHY;

ANIMALS; BINDING SITES; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CRYSTALLOGRAPHY, X-RAY; HUMANS; HYDROGEN BONDING; MICE; MOLECULAR DYNAMICS SIMULATION; MUTAGENESIS, SITE-DIRECTED; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; STATIC ELECTRICITY;

EID: 84907389656     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.08.033     Document Type: Article

References (34)

1. Ash S.C., Yang D.Q., Britt D.E. LYRIC/AEG-1 overexpression modulates BCCIPalpha protein levels in prostate tumor cells. Biochem. Biophys. Res. Commun. 2008, 371:333-338.
2. Birnbaum M.E., Mendoza J.L., Sethi D.K., Dong S., Glanville J., Dobbins J., Ozkan E., Davis M.M., Wucherpfennig K.W., Garcia K.C. Deconstructing the peptide-MHC specificity of T cell recognition. Cell 2014, 157:1073-1087.
3. Blanco M.A., Alečković M., Hua Y., Li T., Wei Y., Xu Z., Cristea I.M., Kang Y. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions. J. Biol. Chem. 2011, 286:19982-19992.
4. Callebaut I., Mornon J.P. The human EBNA-2 coactivator p100: multidomain organization and relationship to the staphylococcal nuclease fold and to the tudor protein involved in Drosophila melanogaster development. Biochem. J. 1997, 321:125-132.
5. Caudy A.A., Ketting R.F., Hammond S.M., Denli A.M., Bathoorn A.M., Tops B.B., Silva J.M., Myers M.M., Hannon G.J., Plasterk R.H. A micrococcal nuclease homologue in RNAi effector complexes. Nature 2003, 425:411-414.
6. Du D., Wang Z., James N.R., Voss J.E., Klimont E., Ohene-Agyei T., Venter H., Chiu W., Luisi B.F. Structure of the AcrAB-TolC multidrug efflux pump. Nature 2014, 509:512-515.
7. Emdad L., Das S.K., Dasgupta S., Hu B., Sarkar D., Fisher P.B. AEG-1/MTDH/LYRIC: signaling pathways, downstream genes, interacting proteins, and regulation of tumor angiogenesis. Adv. Cancer Res. 2013, 120:75-111.
8. Gao X., Ge L., Shao J., Su C., Zhao H., Saarikettu J., Yao X., Yao Z., Silvennoinen O., Yang J. Tudor-SN interacts with and co-localizes with G3BP in stress granules under stress conditions. FEBS Lett. 2010, 584:3525-3532.
9. Gelman I.H. Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12. Cancer Metastasis Rev. 2012, 31:493-500.
10. Guo F., Stanevich V., Wlodarchak N., Sengupta R., Jiang L., Satyshur K.A., Xing Y. Structural basis of PP2A activation by PTPA, an ATP-dependent activation chaperone. Cell Res. 2014, 24:190-203.
11. Hu M., Gu L., Li M., Jeffrey P.D., Gu W., Shi Y. Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway. PLoS Biol. 2006, 4:e27.
12. Lee S.G., Kang D.C., DeSalle R., Sarkar D., Fisher P.B. AEG-1/MTDH/LYRIC, the beginning: initial cloning, structure, expression profile, and regulation of expression. Adv. Cancer Res. 2013, 120:1-38.
13. Leverson J.D., Koskinen P.J., Orrico F.C., Rainio E.M., Jalkanen K.J., Dash A.B., Eisenman R.N., Ness S.A. Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol. Cell 1998, 2:417-425.
14. Li C.L., Yang W.Z., Chen Y.P., Yuan H.S. Structural and functional insights into human Tudor-SN, a key component linking RNA interference and editing. Nucleic Acids Res. 2008, 36:3579-3589.
15. McNicholas S., Potterton E., Wilson K.S., Noble M.E. Presenting your structures: the CCP4mg molecular-graphics software. Acta Crystallogr. D Biol. Crystallogr. 2011, 67:386-394.
16. Meng X., Zhu D., Yang S., Wang X., Xiong Z., Zhang Y., Brachova P., Leslie K.K. Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein. J. Biol. Chem. 2012, 287:4485-4491.
17. Paukku K., Yang J., Silvennoinen O. Tudor and nuclease-like domains containing protein p100 function as coactivators for signal transducer and activator of transcription 5. Mol. Endocrinol. 2003, 17:1805-1814.
18. Ponting C.P. P100, a transcriptional coactivator, is a human homologue of staphylococcal nuclease. Protein Sci. 1997, 6:459-463.
19. Sarkar D., Fisher P.B. AEG-1/MTDH/LYRIC: clinical significance. Adv. Cancer Res. 2013, 120:39-74.
20. Sarkar D., Park E.S., Emdad L., Lee S.G., Su Z.Z., Fisher P.B. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res. 2008, 68:1478-1484.
21. Scadden A.D. The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage. Nat. Struct. Mol. Biol. 2005, 12:489-496.
22. Shaw N., Zhao M., Cheng C., Xu H., Saarikettu J., Li Y., Da Y., Yao Z., Silvennoinen O., Yang J., et al. The multifunctional human p100 protein 'hooks' methylated ligands. Nat. Struct. Mol. Biol. 2007, 14:779-784.
23. Sundström J.F., Vaculova A., Smertenko A.P., Savenkov E.I., Golovko A., Minina E., Tiwari B.S., Rodriguez-Nieto S., Zamyatnin A.A., Välineva T., et al. Tudor staphylococcal nuclease is an evolutionarily conserved component of the programmed cell death degradome. Nat. Cell Biol. 2009, 11:1347-1354.
24. Theobald D.L., Mitton-Fry R.M., Wuttke D.S. Nucleic acid recognition by OB-fold proteins. Annu. Rev. Biophys. Biomol. Struct. 2003, 32:115-133.
25. Thirkettle H.J., Mills I.G., Whitaker H.C., Neal D.E. Nuclear LYRIC/AEG-1 interacts with PLZF and relieves PLZF-mediated repression. Oncogene 2009, 28:3663-3670.
26. Tong X., Drapkin R., Yalamanchili R., Mosialos G., Kieff E. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Mol. Cell. Biol. 1995, 15:4735-4744.
27. Välineva T., Yang J., Palovuori R., Silvennoinen O. The transcriptional co-activator protein p100 recruits histone acetyltransferase activity to STAT6 and mediates interaction between the CREB-binding protein and STAT6. J. Biol. Chem. 2005, 280:14989-14996.
28. Välineva T., Yang J., Silvennoinen O. Characterization of RNA helicase A as component of STAT6-dependent enhanceosome. Nucleic Acids Res. 2006, 34:3938-3946.
29. Wan L., Kang Y. Pleiotropic roles of AEG-1/MTDH/LYRIC in breast cancer. Adv. Cancer Res. 2013, 120:113-134.
30. Wan L., Lu X., Yuan S., Wei Y., Guo F., Shen M., Yuan M., Chakrabarti R., Hua Y., Smith H.A., et al. MTDH-SND1 Interaction Is Crucial for Expansion and Activity of Tumor-Initiating Cells in Diverse Oncogene- and Carcinogen-Induced Mammary Tumors. Cancer Cell 2014, 26:92-105.
31. Wang N., Du X., Zang L., Song N., Yang T., Dong R., Wu T., He X., Lu J. Prognostic impact of Metadherin-SND1 interaction in colon cancer. Mol. Biol. Rep. 2012, 39:10497-10504.
32. Weissbach R., Scadden A.D. Tudor-SN and ADAR1 are components of cytoplasmic stress granules. RNA 2012, 18:462-471.
33. Yang J., Aittomäki S., Pesu M., Carter K., Saarinen J., Kalkkinen N., Kieff E., Silvennoinen O. Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II. EMBO J. 2002, 21:4950-4958.
34. Yoo B.K., Santhekadur P.K., Gredler R., Chen D., Emdad L., Bhutia S., Pannell L., Fisher P.B., Sarkar D. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology 2011, 53:1538-1548.